|
|
Prepublished online as a Blood First Edition Paper on April 3, 2003; DOI 10.1182/blood-2002-11-3502.

Submitted November 19, 2002
Accepted March 24, 2003
Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: significant association with CagA strains of H. pylori in gastric MALT lymphoma
Hongtao Ye, Hongxiang Liu, Ayoma Attygalle, Andrew C Wotherspoon, Andrew G Nicholson, Frederic Charlotte, Veronique Leblond, Paul Speight, John Goodlad, Anne Lavergne-Slove, Jose I Martin-Subero, Reiner Siebert, Ahmet Dogan, Peter G Isaacson, and Ming-Qing Du*
Department of Histopathology, University College London, London, United Kingdom
Department of Histopathology, The Royal Marsden NHS Trust, London, United Kingdom
Department of Histopathology, Royal Brompton Hospital, London, United Kingdom
Service d'Anatomie and Cytologie Pathologiques, Groupe Hospitalier pitie salpetriere, Paris, France
Department of Hematology, Groupe Hospitalier pitie salpetriere, Paris, France
Department of Pathology, Raigmore Hospital, Inverness, Scotland, United Kingdom
Service d'Anatomie Pathologique, Hopital Lariboisiere, Paris, France
Institute of Human Genetics, University Hospital Schleswig-Holstein, Kiel, Germany
* Corresponding author; email: m.du{at}ucl.ac.uk.
T(11;18)(q21;q21) is a specific chromosomal translocation associated with mucosa-associated lymphoid tissue (MALT) lymphoma. It fuses the amino terminal of the API2 gene to the carboxyl terminal of the MALT1 gene and generates a chimeric fusion product. Although the translocation is frequently detected in gastric and pulmonary MALT lymphoma, its incidence in MALT lymphomas from other sites is largely unknown. It also remains unknown whether the occurrence of the translocation is influenced by the nature of preceding diseases associated with MALT lymphomas. We screened for t(11;18)(q21;q21) in 417 cases of MALT lymphoma from 8 major sites by RT-PCR. T(11;18)(q21;q21) was found at highest frequencies in MALT lymphomas from the lung (38%) and stomach (24%), and at moderate frequencies in those from the conjunctiva (19%) and orbit (14%). However, the translocation was only rarely found in MALT lymphomas from the salivary gland (1%) and was absent in those from the thyroid, skin, liver and other rare sites, and in immunoproliferative small intestinal disease (IPSID). In gastric MALT lymphoma, t(11;18)(q21;q21) was significantly associated with infection by CagA positive strains of H. pylori. As CagA positive strains of H. pylori are much more potent in induction of host inflammatory responses including activation of neutrophils, which release highly genotoxic oxygen reactive species, we therefore examined neutrophil infiltration in recognized precursors of MALT lymphoma including H. pylori associated gastritis, lymphoepithelial sialadenitis and Hashimoto's thyroiditis. Neutrophil infiltration was prominent in H. pylori associated gastritis but not in lymphoepithelial sialadenitis and Hashimoto's thyroiditis. Our results demonstrate that t(11;18)(q21;q21) occurs at markedly variable frequencies in MALT lymphoma of different sites and suggest that the occurrence of the translocation is influenced by the nature of pre-malignant diseases associated with MALT lymphoma. Oxidative damage might play a role in development of t(11;18)(q21;q21).

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
Related Article in Blood Online:
-
Radicals accused of causing MALT lymphomas
- Thomas F. E. Barth and Peter Möller
Blood 2003 102: 777-778.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
R. J. Bende, F. van Maldegem, and C. J.M. van Noesel
Chronic inflammatory disease, lymphoid tissue neogenesis and extranodal marginal zone B-cell lymphomas
Haematologica,
August 1, 2009;
94(8):
1109 - 1123.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Stefanovic and I. S. Lossos
Extranodal marginal zone lymphoma of the ocular adnexa
Blood,
July 16, 2009;
114(3):
501 - 510.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-X. Cui, A. Kerby, F. K. E. McDuff, H. Ye, and S. D. Turner
NPM-ALK inhibits the p53 tumor suppressor pathway in an MDM2 and JNK-dependent manner
Blood,
May 21, 2009;
113(21):
5217 - 5227.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Vinatzer, M. Gollinger, L. Mullauer, M. Raderer, A. Chott, and B. Streubel
Mucosa-Associated Lymphoid Tissue Lymphoma: Novel Translocations Including Rearrangements of ODZ2, JMJD2C, and CNN3
Clin. Cancer Res.,
October 15, 2008;
14(20):
6426 - 6431.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Nakamura, H. Ye, C. M. Bacon, A. Goatly, H. Liu, L. Kerr, A. H. Banham, B. Streubel, T. Yao, M. Tsuneyoshi, et al.
Translocations Involving the Immunoglobulin Heavy Chain Gene Locus Predict Better Survival in Gastric Diffuse Large B-Cell Lymphoma
Clin. Cancer Res.,
May 15, 2008;
14(10):
3002 - 3010.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Nakamura, H. Ye, C. M Bacon, A. Goatly, H. Liu, A. H Banham, R. Ventura, T. Matsumoto, M. Iida, Y. Ohji, et al.
Clinical impact of genetic aberrations in gastric MALT lymphoma: a comprehensive analysis using interphase fluorescence in situ hybridisation
Gut,
October 1, 2007;
56(10):
1358 - 1363.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Zhou, H. Ye, J. I. Martin-Subero, S. Gesk, R. Hamoudi, Y.-J. Lu, R. Wang, J. Shipley, R. Siebert, P. G. Isaacson, et al.
The pattern of genomic gains in salivary gland MALT lymphomas
Haematologica,
July 1, 2007;
92(7):
921 - 927.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-S. Chuang, H. Liu, H. Ye, J. I Martin-Subero, R. Siebert, and W.-T. Huang
Pulmonary mucosa-associated lymphoid tissue lymphoma with strong nuclear B-cell CLL/lymphoma 10 (BCL10) expression and novel translocation t(1;2)(p22;p12)/immunoglobulin {kappa} chain-BCL10
J. Clin. Pathol.,
June 1, 2007;
60(6):
727 - 728.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M Bacon, M.-Q. Du, and A. Dogan
Mucosa-associated lymphoid tissue (MALT) lymphoma: a practical guide for pathologists
J. Clin. Pathol.,
April 1, 2007;
60(4):
361 - 372.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B Streubel, G Seitz, M Stolte, P Birner, A Chott, and M Raderer
MALT lymphoma associated genetic aberrations occur at different frequencies in primary and secondary intestinal MALT lymphomas
Gut,
November 1, 2006;
55(11):
1581 - 1585.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Cohen, M. Petryk, M. Varma, P. S. Kozuch, E. D. Ames, and M. L. Grossbard
Non-Hodgkin's Lymphoma of Mucosa-Associated Lymphoid Tissue
Oncologist,
November 1, 2006;
11(10):
1100 - 1117.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. M. Ferreri, M. Ponzoni, M. Guidoboni, A. G. Resti, L. S. Politi, S. Cortelazzo, J. Demeter, F. Zallio, A. Palmas, G. Muti, et al.
Bacteria-eradicating therapy with doxycycline in ocular adnexal MALT lymphoma: a multicenter prospective trial.
J Natl Cancer Inst,
October 4, 2006;
98(19):
1375 - 1382.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Varfolomeev, S. M. Wayson, V. M. Dixit, W. J. Fairbrother, and D. Vucic
The Inhibitor of Apoptosis Protein Fusion c-IAP2{middle dot}MALT1 Stimulates NF-{kappa}B Activation Independently of TRAF1 AND TRAF2
J. Biol. Chem.,
September 29, 2006;
281(39):
29022 - 29029.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Raderer, S. Wohrer, B. Streubel, M. Troch, K. Turetschek, U. Jager, C. Skrabs, A. Gaiger, J. Drach, A. Puespoek, et al.
Assessment of Disease Dissemination in Gastric Compared With Extragastric Mucosa-Associated Lymphoid Tissue Lymphoma Using Extensive Staging: A Single-Center Experience
J. Clin. Oncol.,
July 1, 2006;
24(19):
3136 - 3141.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M-Q Du and J C Atherton
Molecular subtyping of gastric MALT lymphomas: implications for prognosis and management.
Gut,
June 1, 2006;
55(6):
886 - 893.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H Ye, L Gong, H Liu, A Ruskone-Fourmestraux, D de Jong, S Pileri, C Thiede, A Lavergne, H Boot, G Caletti, et al.
Strong BCL10 nuclear expression identifies gastric MALT lymphomas that do not respond to H pylori eradication
Gut,
January 1, 2006;
55(1):
137 - 138.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Fu, D. D. Weisenburger, T. C. Greiner, S. Dave, G. Wright, A. Rosenwald, M. Chiorazzi, J. Iqbal, S. Gesk, R. Siebert, et al.
Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling
Blood,
December 15, 2005;
106(13):
4315 - 4321.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Farinha and R. D. Gascoyne
Molecular Pathogenesis of Mucosa-Associated Lymphoid Tissue Lymphoma
J. Clin. Oncol.,
September 10, 2005;
23(26):
6370 - 6378.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Montalban, A. Santon, C. Redondo, M. Garcia-Cosio, D. Boixeda, E. Vazquez-Sequeiros, F. Norman, C. M. de Argila, I. Alvarez, V. Abraira, et al.
Long-term persistence of molecular disease after histological remission in low-grade gastric MALT lymphoma treated with H. pylori eradication. Lack of association with translocation t(11;18): a 10-year updated follow-up of a prospective study
Ann. Onc.,
September 1, 2005;
16(9):
1539 - 1544.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Levy, C. Copie-Bergman, C. Gameiro, M.-T. Chaumette, M.-H. Delfau-Larue, C. Haioun, A. Charachon, F. Hemery, P. Gaulard, K. Leroy, et al.
Prognostic Value of Translocation t(11;18) in Tumoral Response of Low-Grade Gastric Lymphoma of Mucosa-Associated Lymphoid Tissue Type to Oral Chemotherapy
J. Clin. Oncol.,
August 1, 2005;
23(22):
5061 - 5066.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Zucca and F. Bertoni
Another Piece of the MALT Lymphomas Jigsaw
J. Clin. Oncol.,
August 1, 2005;
23(22):
4832 - 4834.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K.-H. Yeh, S.-H. Kuo, L.-T. Chen, T.-L. Mao, S.-L. Doong, M.-S. Wu, H.-C. Hsu, Y.-S. Tzeng, C.-L. Chen, J.-T. Lin, et al.
Nuclear expression of BCL10 or nuclear factor kappa B helps predict Helicobacter pylori-independent status of low-grade gastric mucosa-associated lymphoid tissue lymphomas with or without t(11;18)(q21;q21)
Blood,
August 1, 2005;
106(3):
1037 - 1041.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Raderer, B. Streubel, S. Woehrer, A. Puespoek, U. Jaeger, M. Formanek, and A. Chott
High Relapse Rate in Patients with MALT Lymphoma Warrants Lifelong Follow-up
Clin. Cancer Res.,
May 1, 2005;
11(9):
3349 - 3352.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Bende, W. M. Aarts, R. G. Riedl, D. de Jong, S. T. Pals, and C. J.M. van Noesel
Among B cell non-Hodgkin's lymphomas, MALT lymphomas express a unique antibody repertoire with frequent rheumatoid factor reactivity
J. Exp. Med.,
April 18, 2005;
201(8):
1229 - 1241.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Al-Saleem and H. Al-Mondhiry
Immunoproliferative small intestinal disease (IPSID): a model for mature B-cell neoplasms
Blood,
March 15, 2005;
105(6):
2274 - 2280.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-H. Kuo, L.-T. Chen, K.-H. Yeh, M.-S. Wu, H.-C. Hsu, P.-Y. Yeh, T.-L. Mao, C.-L. Chen, S.-L. Doong, J.-T. Lin, et al.
Nuclear Expression of BCL10 or Nuclear Factor Kappa B Predicts Helicobacter pylori-Independent Status of Early-Stage, High-Grade Gastric Mucosa-Associated Lymphoid Tissue Lymphomas
J. Clin. Oncol.,
September 1, 2004;
22(17):
3491 - 3497.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. S. Jaffe
Common Threads of Mucosa-Associated Lymphoid Tissue Lymphoma Pathogenesis: From Infection to Translocation
J Natl Cancer Inst,
April 21, 2004;
96(8):
571 - 573.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Wohlfart, D. Sebinger, P. Gruber, J. Buch, D. Polgar, G. Krupitza, M. Rosner, M. Hengstschlager, M. Raderer, A. Chott, et al.
FAS (CD95) Mutations Are Rare in Gastric MALT Lymphoma but Occur More Frequently in Primary Gastric Diffuse Large B-Cell Lymphoma
Am. J. Pathol.,
March 1, 2004;
164(3):
1081 - 1089.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Streubel, D. Huber, S. Wohrer, A. Chott, and M. Raderer
Frequency of Chromosomal Aberrations Involving MALT1 in Mucosa-Associated Lymphoid Tissue Lymphoma in Patients with Sjogren's Syndrome
Clin. Cancer Res.,
January 15, 2004;
10(2):
476 - 480.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. W. Tsang, M. K. Gospodarowicz, M. Pintilie, W. Wells, D. C. Hodgson, A. Sun, M. Crump, and B. J. Patterson
Localized Mucosa-Associated Lymphoid Tissue Lymphoma Treated With Radiation Therapy Has Excellent Clinical Outcome
J. Clin. Oncol.,
November 15, 2003;
21(22):
4157 - 4164.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Conconi, G. Martinelli, C. Thieblemont, A. J. M. Ferreri, L. Devizzi, F. Peccatori, M. Ponzoni, E. Pedrinis, S. Dell'Oro, G. Pruneri, et al.
Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type
Blood,
October 15, 2003;
102(8):
2741 - 2745.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|